Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2019 16:05 ET | Source: Quotient Limited

Quotient Limited to Participate in the Jefferies 2019 Healthcare Conference

JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris...
May 21, 2019 08:00 ET | Source: Quotient Limited

Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents

JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug...
May 14, 2019 16:05 ET | Source: Quotient Limited

Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 14, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter...
May 01, 2019 16:05 ET | Source: Quotient Limited

Quotient Limited Receives European CE Mark for its Initial IH Microarray

JERSEY, Channel Islands, May 01, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...
April 24, 2019 16:05 ET | Source: Quotient Limited

Quotient Limited Announces Initial SDS EU Field Trial Performance Data for MosaiQ™

JERSEY, Channel Islands, April 24, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive EU field trial performance...
March 07, 2019 08:30 ET | Source: Quotient Limited

Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference

JERSEY, Channel Islands, March 07, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris...
February 19, 2019 07:00 ET | Source: Quotient Limited

Quotient Limited to Host Investor Day and Ring Closing Bell at the NASDAQ on March 4, 2019

JERSEY, Channel Islands, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company will host an Investor Day on...
February 15, 2019 08:00 ET | Source: Quotient Limited

Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

JERSEY, Channel Islands, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that today announced that the Company’s Chief...
January 31, 2019 06:00 ET | Source: Quotient Limited

Quotient Limited Provides an Update on Extended Immunohematology Microarray Performance and on the Commencement of the Initial Serological Disease Screening Field Trial together with Third Quarter Fiscal 2019 Results

Development data provides positive results for extended IH microarray panelField trial for initial Serological Disease microarray panel has commenced Reagent revenue growth of 15% in the quarter and...
January 17, 2019 08:00 ET | Source: Quotient Limited

Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call

JERSEY, Channel Islands, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter...